Nov, 7 2021 Britain has become the first country in the world to approve Lagevrio (molnupiravir). The drug is touted as a potential game changer for the management of COVID-19 patients. The Medicines and Healthcare products Regulatory Agency (MHRA), the…
Recent Post
- India Imposes National Ban on Nimesulide for Veterinary Use Due to Toxicity Risks
- Major Relief for MSME Pharma Manufacturers: MoHFW Extends Deadline for Revised GMP Compliance
- Pharmacovigilance system compliance in India
- Simplifying Clinical Trial Amendment Approvals in India
- Navigating Drug Rules in India: A Guide for Pharmaceutical Marketers